| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,796,900 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marriott Thomas B III |
VP, Development Research |
• – – |
2005-06-01 |
4/A |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
14,431 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-06-01 |
4 |
OE |
$11.51 |
$34,530 |
D/D |
3,000 |
2,431 |
|
- |
|
| Groninger James G |
Director |
– • – |
2005-05-23 |
4 |
S |
$12.74 |
$29,939 |
D/D |
(2,350) |
1,000 |
|
- |
|
| Bonney Michael W |
Director |
– • – |
2005-05-17 |
4 |
B |
$12.95 |
$51,800 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-16 |
4/A |
S |
$12.64 |
$78,460 |
D/D |
(6,208) |
11,431 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-16 |
4 |
S |
$12.80 |
$82,454 |
I/I |
(6,441) |
2,300 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-16 |
4 |
S |
$12.64 |
$78,460 |
D/D |
(6,208) |
5,431 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-02 |
4/A |
AS |
$12.15 |
$36,450 |
D/D |
(3,000) |
17,639 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-02 |
4/A |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
20,693 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-05-02 |
4 |
OE |
$12.15 |
$36,450 |
D/D |
3,000 |
20,380 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-04-01 |
4/A |
AS |
$12.78 |
$38,329 |
D/D |
(3,000) |
17,639 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-04-01 |
4/A |
OE |
$6.63 |
$23,288 |
D/D |
3,000 |
20,693 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2005-04-01 |
4 |
OE |
$12.78 |
$38,328 |
D/D |
3,000 |
23,380 |
|
- |
|
| Clark David L |
VP, Corporate Affairs |
• – – |
2005-03-11 |
4 |
B |
$10.97 |
$60,335 |
D/D |
5,500 |
8,722 |
2.74 |
- |
|
| Klein Joseph III |
Director |
– • – |
2005-03-11 |
4 |
B |
$11.05 |
$110,512 |
D/D |
10,000 |
38,100 |
2.39 |
- |
|
| Klein Joseph III |
Director |
– • – |
2005-03-10 |
4 |
B |
$11.27 |
$171,012 |
D/D |
15,000 |
28,100 |
2.39 |
- |
|
| Rauch Alan Mark |
VP, Chief Medical Officer |
• – – |
2005-02-01 |
4 |
AS |
$16.04 |
$18,622 |
D/D |
(1,161) |
255 |
|
- |
|
| Brown Morgan R |
Vice President, Finance |
• – – |
2005-02-01 |
4 |
AS |
$16.19 |
$14,540 |
D/D |
(898) |
0 |
|
- |
|
| Mueller Alan L |
VP, Drug Discovery |
• – – |
2005-02-01 |
4 |
AS |
$16.19 |
$21,793 |
D/D |
(1,346) |
0 |
|
- |
|
| Mueller Alan L |
VP, Drug Discovery |
• – – |
2005-02-01 |
4 |
AS |
$16.19 |
$7,561 |
I/I |
(467) |
0 |
|
- |
|
| Rauch Alan Mark |
VP, Chief Medical Officer |
• – – |
2005-01-31 |
4 |
A |
$14.03 |
$19,158 |
D/D |
1,366 |
1,416 |
|
- |
|
| Brown Morgan R |
Vice President, Finance |
• – – |
2005-01-31 |
4 |
A |
$14.03 |
$12,594 |
D/D |
898 |
898 |
|
- |
|
| Mueller Alan L |
VP, Drug Discovery |
• – – |
2005-01-31 |
4 |
A |
$14.03 |
$18,878 |
D/D |
1,346 |
1,346 |
|
- |
|
| Mueller Alan L |
VP, Drug Discovery |
• – – |
2005-01-31 |
4 |
A |
$14.03 |
$6,550 |
I/I |
467 |
467 |
|
- |
|
| Heath G Thomas |
VP, Marketing and Sales |
• – – |
2005-01-31 |
4 |
A |
$14.03 |
$6,606 |
D/D |
471 |
2,322 |
|
- |
|
574 Records found
|
|
Page 12 of 23 |
|
|
